DDAH2 Antibody

文獻(xiàn)引用 (1) 說明書

中文名稱：

DDAH2兔多克隆抗體
貨號(hào)：

CSB-PA006580LA01HU
規(guī)格：

￥440
圖片：
Western Blot
Positive WB detected in: Mouse lung tissue, Mouse kidney tissue
All lanes: DDAH2 antibody at 2.5μg/ml
Secondary
Goat polyclonal to rabbit IgG at 1/50000 dilution
Predicted band size: 30 kDa
Observed band size: 30, 50 kDa

Immunohistochemistry of paraffin-embedded human ovarian tissue using CSB-PA006580LA01HU at dilution of 1:100
其他：

產(chǎn)品詳情
產(chǎn)品評價(jià)
引用文獻(xiàn)
相關(guān)產(chǎn)品
靶點(diǎn)詳情

產(chǎn)品詳情

產(chǎn)品名稱：

Rabbit anti-Homo sapiens (Human) DDAH2 Polyclonal antibody
Uniprot No.：

O95865
基因名：

DDAH2
別名：

DDAH antibody; DDAH II antibody; DDAH-2 antibody; DDAH2 antibody; DDAH2_HUMAN antibody; DDAHII antibody; Dimethylargininase 2 antibody; Dimethylargininase-2 antibody; Dimethylarginine dimethylaminohydrolase 2 antibody; Dimethylarginine dimethylaminohydrolase II antibody; G6a antibody; N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 antibody; NG dimethylarginine dimethylamino hydrolase homolog antibody; NG30 antibody; OTTHUMP00000029307 antibody; OTTHUMP00000029310 antibody; OTTHUMP00000174488 antibody; OTTHUMP00000174489 antibody; Protein G6a antibody; S phase protein antibody; S-phase protein antibody
宿主：

Rabbit
反應(yīng)種屬：

Human, Mouse
免疫原：

Recombinant Human N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 protein (1-285AA)
免疫原種屬：

Homo sapiens (Human)

標(biāo)記方式：

Non-conjugated

本頁面中的產(chǎn)品，DDAH2 Antibody (CSB-PA006580LA01HU)，的標(biāo)記方式是Non-conjugated。對于DDAH2 Antibody，我們還提供其他標(biāo)記。見下表：

標(biāo)記方式	貨號(hào)	產(chǎn)品名稱	應(yīng)用
HRP	CSB-PA006580LB01HU	DDAH2 Antibody, HRP conjugated	ELISA
FITC	CSB-PA006580LC01HU	DDAH2 Antibody, FITC conjugated
Biotin	CSB-PA006580LD01HU	DDAH2 Antibody, Biotin conjugated	ELISA

克隆類型：

Polyclonal
抗體亞型：

IgG
純化方式：

>95%, Protein G purified
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
產(chǎn)品提供形式：

Liquid
應(yīng)用范圍：

ELISA, WB, IHC

推薦稀釋比：

Application	Recommended Dilution
WB	1:500-1:5000
IHC	1:20-1:200

Protocols：

ELISA Protocol
Western Blotting (WB) Protocol
Immunohistochemistry (IHC) Protocol
儲(chǔ)存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

引用文獻(xiàn)

L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory Drugs M Krzystek-Korpacka,Cancers,2020

產(chǎn)品評價(jià)

靶點(diǎn)詳情

功能：

Hydrolyzes N(G),N(G)-dimethyl-L-arginine (ADMA) and N(G)-monomethyl-L-arginine (MMA) which act as inhibitors of NOS. Has therefore a role in the regulation of nitric oxide generation.
基因功能參考文獻(xiàn)：
1. genetic variations in the DDAH2 gene may influence the ADMA concentration and erythropoietin resistance in MHD patients PMID: 28590543
2. The main finding from this study was that it demonstrated that the C-allele of rs3087894 in DDAH1 is a risk factor for hypertension in the Kazakh group but a protective factor in the Uygur group. In addition, we did not find any genotype of DDAH1 and DDAH2 associated with hypertension in the Han group. PMID: 26786611
3. Exogenous human DDAH2 gene promotes differentiation of rabbit bone marrow-derived endothelial progenitor cells into mature endothelial cells. PMID: 28150318
4. expression of DDAH2 is associated with invasiveness of lung adenocarcinoma via tumor angiogenesis PMID: 26515557
5. Inhibiting the expression of DDAH1, but not DDAH2, resulted in a significant increase in the sensitivity of the EVT cell line SGHPL-4 to tumour necrosis factor related apoptosis inducing ligand (TRAIL) induced apoptosis PMID: 26082478
6. increased ADMA levels in rheumatoid arthritis do not appear to relate to DDAH genetic polymorphisms PMID: 25194333
7. The percentage of senescent endothelial progenitor cells increased while the expression of DDAH2 decreased concomitantly with an increase in the plasma levels of asymmetric dimethylarginine in patients with type 2 diabetes mellitus. PMID: 25701782
8. DDAH-1 is a specific molecular target for portal pressure reduction, through actions on ADMA-mediated regulation of eNOS activity. PMID: 25152204
9. Our results suggest that the rs805304 C allele of the DDAH gene was associated with decreased risk of myocardial infarction and decreased risk of obesity. PMID: 25236572
10. Homocysteine disrupts EPCs function via inducing the hypermethylation of DDAH2 promoter, suggesting a key role of epigenetic mechanism in the progression of atherosclerosis PMID: 24934151
11. -476 to -469 of the DDAH2 promoter was a NF-kB responsive element and is important for the transactivation of DDAH2. PMID: 24928011
12. The rs9267551 functional variant of the DDAH2 gene is associated with chronic kidney disease with carriers of the C allele having a lower risk of renal dysfunction independently from several confounders PMID: 24125425
13. Our approaches revealed signature candidates of differentially hypermethylated genes of DDAH2 and DUSP1 which can be further developed as potential biomarkers for OSCC as diagnostic, prognostic and therapeutic targets in the future. PMID: 24155659
14. Enhancing pulmonary DDAH II activity attenuates LPS-mediated lung leak in acute lung injury. PMID: 24134589
15. There is a significant difference in distribution of DDAH2 gene polymorphism among hemodialysis patients compared to healthy individuals. PMID: 23770786
16. DDAH2-1151 A/C polymorphism is associated with Chronic renal impairment in type 2 diabetes. PMID: 23129820
17. Glucose-stimulated insulin secretion is increased in Ddah2-transgenic pancreatic islets by 33%, compared to its levels in wild-type mice. PMID: 23430976
18. Suppression of DDAH2 expression is a culprit for homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells. PMID: 23171931
19. Found that SNP rs2272592 in DDAH2 is associated with type 2 diabetes but SNP rs805304 in DDAH2 is not. DDAH2 SNP rs2272592 AG+GG genotypes are associated with genetic susceptibility to type 2 diabetes in Korean population. PMID: 22579530
20. No association was observed between the DDAH2 polymorphisms at rs805305 and rs2272592 and coronary heart disease. PMID: 22923027
21. A functional polymorphism of the DDAH2 gene may confer increased risk for type 2 diabetes by affecting insulin sensitivity PMID: 22558392
22. The -449G single nucleotide polymorphism within the DDAH2 gene was associated with both decreased plasma asymmetric dimethylarginine and an increased likelihood of presenting with "cold" shock in pediatric sepsis. PMID: 22428028
23. DDAH-2 could play an important role in IL-1beta-induced NO production and in osteoarthritis pathogenesis. PMID: 21898353
24. Low expression of DDAH-2 in placenta and increased serum asymmetric dimethylarginine level might confer susceptibility to preeclampsia. PMID: 19570459
25. a possible association between A allele / AA genotype for DDAH2 SNP1 (-1151 C/A, rs805304) and G allele / GG genotype for SNP2 (-449 C/G, rs805305) with CVD in male 35-50 year-old Egyptian patients was observed. PMID: 21677405
26. DDAH1 and DDAH2 polymorphisms are strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes PMID: 20209122
27. Single nucleotide polymorphisms in the DDAH2 gene are associated with blood pressure levels, prevalence of hypertension, and left ventricular mass and function in the general population. PMID: 19666123
28. In cultured endothelial cells, heterologously expressed human DDAH II was S-nitrosylated after cytokine induced expression of the inducible NOS isoforms. PMID: 12370443
29. DDAH2 expression in endothelial cells is altered by genetic variation in a basal promoter element PMID: 14550280
30. messenger RNA and protein were demonstrated in first trimester placental tissue, primary extravillous trophoblasts and extravillous trophoblast-derived cell lines. PMID: 16920729
31. Allelic variation for a polymorphism in the DDAH II gene may influence asymmetrical dimethyl arginine concentrations, hence the severity of organ failure in septic shock patients. PMID: 17002794
32. The purpose of this study was to investigate whether there is any association between preeclampsia and eNOS, DDAH, and VEGF gene polymorphisms.Polymorphisms in eNOS, DDAH, and VEGF gene do not seem to be risk factors for preeclampsia. PMID: 18251679
33. Lysophosphatidylcholine (LPC) impairs DDAH/ADMA/NOS/NO pathway, and DDAH2 gene transfer could improve the LPC-elicited impairments in endothelial cells. PMID: 18342305
34. results suggest that the DDAH2 common variant may play a protective role in the development of Intracerebral Hemorrhage, implicating that the DDAH2/ADMA pathway may act as a critical regulator of cerebral small-vessel disorders PMID: 19250061
35. DDAH2 mRNA expression is inversely associated with some cardiovascular risk-related features. PMID: 19822957
顯示更多

收起更多
亞細(xì)胞定位：

Cytoplasm. Mitochondrion. Note=Translocates from cytosol to mitochondrion upon IL-1beta stimulation in chondrocytes.
蛋白家族：

DDAH family
組織特異性：

Detected in heart, placenta, lung, liver, skeletal muscle, kidney and pancreas, and at very low levels in brain.
數(shù)據(jù)庫鏈接：

HGNC: 2716

OMIM: 604744

KEGG: hsa:23564

STRING: 9606.ENSP00000364943

UniGene: Hs.247362

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human